Cefdinir:: A comparative study of anhydrous vs. monohydrate form Microstructure and tabletting behaviour

被引:20
作者
Cabri, Walter
Ghetti, Paolo
Alpegiani, Marco
Pozzi, Giovanni
Justo-Erbez, Angel
Perez-Martinez, Jose Ignacio
Villalon-Rubio, Rosario
Monedero-Perales, M. Carmen
Munoz-Ruiz, Angel
机构
[1] Univ Seville, Fac Pharm, Dept Pharm & Pharmaceut Technol, E-41012 Seville, Spain
[2] Antibioticos Spa, R&D Dept, Milan, Italy
[3] Inst Mat Sci Seville, Seville, Spain
关键词
cefdinir; tablets; X-ray diffraction; dissolution profiles; microstructural analysis;
D O I
10.1016/j.ejpb.2006.05.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Anhydrous cefdinir (AC) vs. monohydrated cefdinir (MHC) was compared in order to be used as antimicrobial in therapeutics. Different techniques have been used to characterize physically AC and MHC, and also a complete microstructural analysis of raw materials was carried out. Cefdinir and Maltodextrin QDM (R) 500 (3:2) formulations were compressed in order to obtain tablets with typical dose of Cefdinir, i.e. 300 mg. Dissolution profiles were obtained for both AC and MHC tablets. Finally tablet X-ray diffraction was performed to ensure the stability of the monohydrated form after tabletting being clearly different in both AC and MHC crystals. AC crystal structure was agreed with the known pattern of anhydrous Cefdinir described in the literature. Microstructural analysis showed large differences in specific surface area (SSA), confirmed by mercury intrusion. Crystal structures of both AC and MHC were stable under mixing, compression and storing processes. Dissolution profiles were faster for hydrate form, probably related to microstructural properties of the crystal which remained after tabletting. In conclusion, it is possible to isolate Cefdinir in two forms anhydrous and monohydrate, well characterized and differentiated. The use of this later improves dissolution of tablet dosage form due to the lack of interconversion during tablet manufacture. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:212 / 221
页数:10
相关论文
共 37 条
[1]  
AVNIR D, 1989, FRACTAL APPROACH HET, P78
[2]   Pharmaceutical evaluation of early development candidates "the 100 mg-approach" [J].
Balbach, S ;
Korn, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) :1-12
[3]   Spectral methods for the characterization of polymorphs and solvates [J].
Brittain, HG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) :405-412
[4]  
Brittain HG, 1999, DRUGS PHARM SCI, V95, P73
[5]   Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry [J].
Cao, WJ ;
Bates, S ;
Peck, GE ;
Wildfong, PLD ;
Qiu, ZH ;
Morris, KR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (04) :1111-1119
[6]   EFFECT OF HUMIDITY ON FORM OF WATER-RETENTION IN A POWDER [J].
COELHO, MC ;
HARNBY, N .
POWDER TECHNOLOGY, 1978, 20 (02) :197-200
[7]   Use of glancing angle x-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets [J].
Debnath, S ;
Predecki, P ;
Suryanarayanan, R .
PHARMACEUTICAL RESEARCH, 2004, 21 (01) :149-159
[8]   Thermal analysis and powder X-ray diffraction study of terpin - Evidence of a eutectic 'hydrate/anhydrous form' [J].
Di Martino, P ;
Piva, F ;
Conflant, P ;
Guyot-Hermann, AM .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 1999, 57 (01) :95-109
[9]   Physical characterization of naproxen sodium hydrate and anhydrate forms [J].
Di Martino, P ;
Barthélémy, C ;
Palmieri, GF ;
Martelli, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (04) :293-300
[10]   USE OF FRACTAL GEOMETRY ON THE CHARACTERIZATION OF PARTICLES MORPHOLOGY - APPLICATION TO THE DICLOFENAC HYDROXYETHYLPIRROLIDINE SALT [J].
FERNANDEZHERVAS, MJ ;
HOLGADO, MA ;
RABASCO, AM ;
FINI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 108 (03) :187-194